Nike (NKE) Is Healing. Just Not Fast Enough Yet

Nike (NKE) confirms that its turnaround is gaining traction but remains incomplete. Fiscal Q3 2026 results beat expectations but left key recovery questions unanswered. The brand remains intact, North America is healing, and management has a credible path forward. However, margins, China, Europe, the Middle East, and Africa (EMEA) revenues, and cash flow still do not justify a valuation that sits above the company’s own historical norms.

Nike is the world’s largest athletic footwear and apparel company, operating through wholesale partners and NIKE Direct channels under the NIKE, Jordan, and Converse brands. I rate NKE a Hold and suggest waiting for clearer evidence of margin and earnings recovery before committing to Nike shares.

Fiscal Q3 2026 Beat the Estimate, but Channels Tell a Split Story

Nike’s Fiscal Q3 2026 earnings report, released on March 31, showed incremental progress even as tariffs, restructuring charges, and a deliberate pullback in Greater China weighed on margins and revenue. Total revenues of $11.28 billion were flat on a reported basis and down 3% on a currency-neutral basis, slightly beating the consensus estimate of $11.24 billion. Diluted earnings per share (EPS) of $0.35 exceeded estimates of roughly $0.28, even as net income fell 35% year-over-year to $520 million.

Wholesale revenues grew 5% to $6.5 billion, with North America wholesale up 11%, reflecting stronger retailer demand. February 2026 marked North America’s first positive all-channel growth in two years. NIKE Running grew over 20%, and management cited the category as an early proof point for the “Win Now” strategy.

However, NIKE Direct revenues fell 7% on a currency-neutral basis to $4.5 billion, and NIKE Brand Digital declined 9%. Gross margin contracted 130 basis points (bps) to 40.2%, including a roughly 300-bps headwind from higher U.S. tariffs. Overall, the revenue beat is encouraging, but beating a low bar while net income falls 35% and digital declines across every channel is not the sustained improvement that would justify adding to positions.

Greater China and EMEA Confirm Why This Is Still a Waiting Game

International markets remain the clearest evidence that Nike’s turnaround is still incomplete. Greater China revenue declined 10% in Q3. Management guided roughly 20% year-over-year declines for Fiscal Q4 as Nike intentionally ships less product to retail partners to clear excess inventory from store shelves.

Meanwhile, EMEA revenue fell 7%, and Nike is relying on increased discounting to move rising inventory entering Q4, a dynamic that will further pressure gross margin before it improves. The cost of that reset is already visible: Nike recorded a $230 million employee-related severance charge in Q3 and announced an additional 1,400 job cuts in April 2026, underscoring how much structural work remains before the recovery translates into earnings.

Management still expects gross margin expansion beginning in Fiscal Q2 2027 as restructuring actions clear by calendar year-end, but investors are funding that recovery before seeing proof in the numbers. Nike is also attempting to reignite demand ahead of the 2026 FIFA World Cup through marketing spend and shopping initiatives enabled by artificial intelligence (AI), in partnership with Alphabet Inc. (GOOGL). Yet both steps remain future catalysts with no near-term revenue impact.

The Valuation Is ahead of the Recovery

Nike’s forward P/E of approximately 25.7x is higher than that of the Apparel Retailing industry, which stands at 20.2x. It also exceeds the multiples of direct peers: Lululemon Athletica (LULU) trades at approximately 9.7x forward earnings, while Columbia Sportswear (COLM) trades at approximately 14.9x forward P/E.

Nike potentially deserves a brand premium, but with EPS declining approximately 49.5% year-over-year and margins still compressed by tariffs and restructuring charges, the current multiple prices in a Fiscal 2027 recovery that remains unconfirmed.

The board declared a $0.41 quarterly dividend payable July 1, extending the company’s 17-year streak of consecutive annual dividend increases. The 2.81% yield provides some support, but the payout ratio stands near 94.7%, while the trailing-12-month free cash flow of $1.05 billion covers the annual dividend obligation only narrowly. A dividend cut for Nike stock is not the base case, but it is no longer an abstract risk if margin recovery takes longer than expected.

A Covered Call Strategy Can Help Existing Holders Generate Income

For investors who hold NKE through brokerage accounts that permit options trading, selling a slightly in-the-money (ITM) covered call can generate meaningful income while the recovery develops. With NKE’s 30-day implied volatility (IV) running at roughly 38%, the July 17 expiry $42.5 strike call option is currently bid at approximately $3.10 per share, which lowers the effective cost basis and provides income well above Nike’s quarterly dividend alone. The trade-off is straightforward: if NKE rallies sharply above the $42.5 strike before expiry, upside participation is capped at that level.

Three ETFs for Consumer Discretionary Exposure without NKE Risk

For investors seeking NKE exposure without single-stock risk, three exchange-traded funds (ETFs) offer differentiated approaches. The FT Cboe Vest DJIA Dogs 10 Target Income ETF (DOGG) holds approximately 5.2% in NKE, combining Dow Jones Industrial Average (DJIA) income stocks with a covered call overlay for additional income. The Invesco Dow Jones Industrial Average Dividend ETF (DJD) allocates roughly 3.7% to NKE in a yield-weighted DJIA basket. Finally, the Global X Millennial Consumer ETF (MILN) holds NKE at approximately 2.9%, with a focus on millennial consumer spending.

Is NKE Stock a Buy, Sell, or Hold?

Nike currently carries a Moderate Buy consensus rating on TipRanks, based on 26 analyst ratings assigned in the past three months, consisting of 14 Buys, 12 Holds, and no Sells. The average 12-month price target for NKE is $59.95, implying upside of approximately 35% from the current share price of approximately $44.39.

Conclusion

Nike’s recovery is becoming more visible operationally, particularly in North America wholesale trends, but the financial recovery still lags. Margins remain pressured, China and EMEA sales have not stabilized, and free cash flow coverage of the dividend remains tight.

The stock is materially cheaper than a year ago, but the forward P/E of roughly 25.7x still sits above those of NKE peers or the apparel retail industry average. Nike remains a world-class brand, but the market continues to price in a normalized earnings recovery that current fundamentals have not yet delivered. The 2.81% yield is a cushion, not a thesis, and the risk-reward profile continues to support a Hold rating.